ÂÜÀòÂÒÂ×

Dr. Patrick Schorderet, MBA, serves as the Global Head of Strategy, Data Science and Innovation at Novo Nordisk, where efforts focus on advancing digital and data transformation in R&D through AI and GenAI to enhance drug discovery. Additionally, Dr. Schorderet is a Visiting Lecturer in Value-Based Healthcare at the University of Copenhagen and has previously held significant roles such as Digital Innovation Strategy Director at Novartis and Leader of EU Digital & Innovation in Pharma Advisory at PwC Switzerland. Dr. Schorderet's extensive educational background includes a PhD in Genetics/Genomics from EPFL, an MA in Finance from Harvard University, an MBA from Quantic School of Business and Technology, an MS in Stem Cells from MIT, and advanced studies in Accounting, Management, and Analytics from Harvard Business School Online, alongside training in Negotiation from Harvard Law School.